Seattle vaccine and treatment testing unit
University of Washington Vaccine and Treatment Evaluation Unit
The UW unit runs vaccine and treatment testing for respiratory illnesses, sexually transmitted infections, malaria, and gut infections for children and adults in Seattle and partner sites worldwide.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11296936 on NIH RePORTER |
What this research studies
You would be joining clinical testing run by experienced teams based at Harborview Medical Center and partner sites like Seattle Children’s and Fred Hutch. The unit conducts domestic and international trials for respiratory infections, STIs, malaria challenge studies, enteric infections, and other neglected tropical diseases. The team has run more than 30 clinical trials under investigational protocols and has established recruitment, enrollment, and retention practices to protect participants and support follow-up. Trials may involve clinic visits, laboratory testing, and sometimes controlled challenge or investigational products under IND protocols.
Who could benefit from this research
Good fit: Ideal candidates are children or adults who have, are at risk for, or meet specific eligibility criteria for trials of respiratory, sexually transmitted, malaria, enteric, or related infections at UW or partner sites.
Not a fit: People without the targeted infections, who do not meet trial eligibility, or who cannot attend required clinic visits are unlikely to receive direct benefit.
Why it matters
Potential benefit: If successful, this program could speed access to new vaccines and treatments and improve prevention and care for infectious diseases.
How similar studies have performed: Similar VTEU- and NIAID-sponsored trials have previously contributed to successful vaccine and treatment advances, so the approach is well established.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Wald, Anna — University of Washington
- Study coordinator: Wald, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.